PHARMACY

Updox launches secure text and messenger
Updox's secure text and messenger tools are designed to communicate with patients and help coordinate care between providers.
FDA approves Gamifant for ultra-rare illness
Sobi and Novimmune will bring Gamifan to patients with HLH, an ultra-rare syndrome of hyper-inflammation.

Pharmacy software, tech focus on outcomes, clinical interventions

From drive-through to refill reminders, makers of pharmacy software and technology solutions are looking to make it easier for pharmacists to focus on their patients, rather than administrative tasks.
MinuteClinic gets Joint Commission’s Gold Seal of Approval for ambulatory care

CVS Health's MinuteClinic has received its fifth consecutive accreditation from The Joint Commission.
CVS Health expects Aetna deal to close after Thanksgiving

CVS Health's $69 million purchase of health insurer Aetna won't close until after Thanksgiving as it awaits approval of remaining two states.
Q&A: McKesson HVS’ Tammaro talks customized central fill

Drug Store News spoke with McKesson High Volume Solutions vice president of sales, Joe Tammaro, to discuss the role automation plays in a successful central-fill pharmacy.
Glenmark gets FDA nod for generic Finacea gel

Glenmark has received the FDA's blessing for generic Finacea gel, which had a market value of about $64.1 million.
Indivior gets FDA nod for Perseris

Indivior’s once-monthly Perseris now offers a new option for treating adults with schizophrenia.
Hikma unveils generic Halcion

Hikma is introducing generic Halcion, which had a market value of about $27 million for the year ended September 2018, according to IQVIA data.
FDA clears new indication for Promacta

The FDA's approval for a new indication for Promacta provides a new treatment for a rare life-threatening disease.